Isoniazid/pyridoxine/sulfamethoxazole/trimethoprim
| Combination of | |
|---|---|
Anti-tuberculosis medication | |
| Pyridoxine | Vitamin |
| Sulfamethoxazole | Antibiotic |
| Trimethoprim | Antibiotic |
| Clinical data | |
| Routes of administration | By mouth[1] |
| ATC code | ) |
Isoniazid/pyridoxine/sulfamethoxazole/trimethoprim (INH/B6/CTX) is a
fixed-dose combination medication for the prevention of opportunistic infections in HIV/AIDS.[1] It combines isoniazid, pyridoxine, sulfamethoxazole, and trimethoprim.[1] Specifically it is used to prevent tuberculosis, toxoplasmosis, pneumonia, malaria, and isosporiasis.[2] It is taken by mouth.[1]
Side effects may include trouble concentrating, numbness, vomiting, and rash.
It is on the World Health Organization's List of Essential Medicines.[1] While benefits include being able to take less pills, it is unclear if this version changes peoples adherence to treatment.[2] Other studies, however, have found fixed-dose combinations to be useful for this purpose.[2]
References
- ^ hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
- ^ a b c d e f g "Isoniazid + pyridoxine + sulfamethoxazole + trimethoprim (New formulation) -- Adults". World Health Organization (WHO). Archived from the original on July 30, 2015. Retrieved 13 December 2017.
